677 results on '"Lançon, C."'
Search Results
2. The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort
3. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort
4. Comparison of three scales (BIS, SUMD and BCIS) for measuring insight dimensions and their evolution after one-year of follow-up: Findings from the FACE-SZ Cohort
5. Repeated bullying at the workplace in medical students and young doctors: the MESSIAEN national study
6. Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort
7. Childhood Trauma increases suicidal behaviour in a treatment-resistant depression population: a FACE-DR report
8. Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study
9. Hazardous drinking is associated with hypnotic consumption in medical students in the BOURBON nationwide study: psychological factors explored
10. Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission.
11. Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort
12. Sexual-orientation based discrimination is associated with anxiety and depression in young physicians. A national study.
13. Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohort.
14. Sexual harassment exposure and impaired mental health in medical students. The MESSIAEN national study
15. Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort
16. First-year French medical students consume antidepressants and anxiolytics while second-years consume non-medical drugs.
17. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia
18. Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode
19. Measuring the Patient Experience of Mental Health Care: A Systematic and Critical Review of Patient-Reported Experience Measures
20. Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia
21. Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort
22. Anxiolytic consumption is associated with tobacco smoking and severe nicotine dependence. Results from the national French medical students (BOURBON) study
23. Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort
24. Relationship between childhood trauma and level of insight in schizophrenia: A path-analysis in the national FACE-SZ dataset
25. Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort
26. Psychiatric and psychological follow-up of undergraduate and postgraduate medical students: Prevalence and associated factors. Results from the national BOURBON study
27. A multi-dimensional approach to the relationship between insight and aggressiveness in schizophrenia: Findings from the FACE-SZ cohort
28. Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
29. Deep brain stimulation in the treatment of obsessive-compulsive disorder: current perspectives
30. Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset
31. Psychiatric disability as mediator of the neurocognition-functioning link in schizophrenia spectrum disorders: SEM analysis using the Evaluation of Cognitive Processes involved in Disability in Schizophrenia (ECPDS) scale
32. Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort
33. Venus and Mars on the benches of the faculty: Influence of gender on mental health and behavior of medical students. Results from the BOURBON national study
34. Evolution under testosterone of a gender dysphoria in a Klinefelter syndrome
35. Évolution sous testostérone d’une dysphorie de genre dans un syndrome de Klinefelter
36. Psychiatry: A discipline at specific risk of mental health issues and addictive behavior? Results from the national BOURBON study
37. Factors associated with direct health care costs in schizophrenia: Results from the FACE-SZ French dataset
38. Increase of precuneus metabolism correlates with reduction of PTSD symptoms after EMDR therapy in military veterans: an 18F-FDG PET study during virtual reality exposure to war
39. Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort
40. Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort
41. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort
42. Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort
43. A Pharmacoeconomic Evaluation of Zuclopenthixol Compared with Haloperidol and Risperidone in the Treatment of Schizophrenia
44. Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental)
45. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort
46. Psychometric properties of the Ruminative Response Scale-short form in a clinical sample of patients with major depressive disorder
47. Validity of a common quality of life measurement in homeless individuals with bipolar disorder and schizophrenia
48. Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia
49. Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental
50. Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.